Skip to main content
. 2024 Sep 18;19:576. doi: 10.1186/s13018-024-04895-6

Table 3.

Demographic and comorbidity characteristics for patients

Total Bimalleolar Fracture Lateral Malleolus Fracture Trimalleolar Fracture Medial Malleolus Fracture Distal Tibiofibular Joint Disruption Ankle Dislocation Posterior Malleolus
n (%) (SD)
Patients, N (%) 29,905 (100%) 10,877 (36.37%) 7828 (26.18%) 7740 (25.88%) 1524 (5.10%) 1481 (4.95%) 244 (0.82%) 211 (0.71%)
Age (years, mean ± SD) 49.6 ± 18.40 52.4 ± 18.70 45.3 ± 17.5 53.1 ± 17.40 42.4 ± 18.20 41.4 ± 16.50 49.3 ± 18.60 44.4 ± 16.80
BMI (kg/m2, mean ± SD) 30.9 ± 7.10 30.9 ± 7.10 30.8 ± 7.0 31.0 ± 7.0 29.2 ± 6.70 32.3 ± 7.50 31.6 ± 7.0 30.3 ± 6.20
Male sex 12,206 (40.81%) 3874 (35.6%) 4023 (51.40%) 2125 (27.50%) 911 (59.80%) 1027 (69.30%) 123 (50.40%) 123 (58.30%)
Operative Time (mins, mean ± SD) 77.2 ± 45.20 78.10 ± 42 62.7 ± 34.60 96.8 ± 51.30 62.2 ± 43.90 60.2 ± 41.70 79.1 ± 50.90 76.7 ± 51.20
Length of Stay (mean ± SD) 1.57 ± 3.67 1.93 ± 3.95 0.89 ± 3.38 2.02 ± 3.81 0.90 ± 2.90 0.77 ± 1.91 2.55 ± 4.25 1.15 ± 2.49
Outpatient status 19,643 (65.68%) 6453 (59.30%) 6168 (78.80%) 4446 (57.40%) 1203 (78.90%) 1115 (75.30%) 111 (45.50%) 147 (69.70%)
ASA Class (mean ± SD) 2.1 ± 0.70 2.2 ± 0.80 2.0 ± 0.70 2.2 ± 0.70 1.9 ± 0.70 1.9 ± 0.70 2.3 ± 0.80 2.1 ± 0.8
1 (no disturbance) 5701 (19.06%) 1778 (16.30%) 1889 (24.10%) 1069 (13.80%) 443 (29.10%) 425 (28.70%) 38 (15.60%) 59 (28%)
2 (mild disturbance) 15,197 (50.82%) 5340 (49.10%) 4128 (52.70%) 4021 (52%) 769 (50.50%) 749 (50.60%) 103 (42.20%) 87 (41.20%)
3 (severe disturbance) 8220 (27.49%) 3376 (31%) 1707 (21.80%) 2420 (31.30%) 289 (19%) 283 (19.10%) 87 (35.70%) 58 (27.50%)
4 (life-threatening disturbance) 783 (2.62%) 382 (3.50%) 103 (1.30%) 229 (3%) 23 (1.50%) 23 (1.60%) 16 (6.60%) 7 (3.30%)
5 (moribund) 4 (0.013%) 1 (0%) 1 (0%) 1 (0%) 0 (0%) 1 (0.10%) 0 (0%) 0 (0%)
Race
White 18,309 (61.22%) 6461 (59.40%) 4637 (59.20%) 5256 (67.90%) 912 (59.80%) 803 (54.20%) 139 (57%) 101 (47.90%)
Black 2929 (9.79%) 1006 (9.25%) 892 (11.40%) 679 (8.80%) 155 (10.20%) 158 (10.70%) 26 (10.70%) 13 (6.20%)
Asian 554 (1.85%) 178 (1.60%) 156 (2%) 142 (1.80%) 41 (2.70%) 30 (2%) 4 (1.60%) 3 (1.40%)
Other 8113 (27.13%) 3232 (29.70%) 2143 (27.40%) 1663 (21.50%) 416 (27.30%) 490 (33.10%) 75 (30.70%) 94 (44.50%)
Morbidity Probability (mean ± SD) 0.023 ± 0.02 0.028 ± 0.022 0.015 ± 0.011 0.026 ± 0.021 0.013 ± 0.011 0.018 ± 0.014 0.052 ± 0.048 0.015 ± 0.017
Mortality Probability (mean ± SD) 0.002 ± 0.007 0.002 ± 0.007 0.001 ± 0.003 0.003 ± 0.009 0.001 ± 0.003 0.001 ± 0.002 0.007 ± 0.019 0.004 ± 0.020
Dependent functional status (partial or total) 770 (2.58%) 346 ± 3.20 129 (1.60%) 224 (2.90%) 27 (1.80%) 27 (1.80%) 11 (4.50%) 6 (2.80%)
Current smoker 6776 (22.66%) 2388 ± 22 1870 (23.90%) 1673 (21.60%) 387 (25.40%) 354 (23.90%) 55 (22.50%) 49 (23.20%)
Comorbidities N (%)
Congestive heart failure 224 (0.75%) 106 (1%) 24 (0.30%) 75 (1%) 5 (0.30%) 3 (0.20%) 8 (3.30%) 3 (1.40%)
Dialysis 184 (0.62%) 85 (0.80%) 24 (0.30%) 62 (0.80%) 7 (0.50%) 4 (0.30%) 2 (0.80%) 0 (0%)
Steroid use 561 (1.88%) 232 (2.10%) 121 (1.50%) 169 (2.20%) 17 (1.10%) 16 (1.10%) 2 (0.80%) 4 (1.90%)
Hypertension 9308 (31.13%) 3766 (34.60%) 2022 (25.80%) 2771 (35.80%) 307 (20.10%) 321 (21.70%) 80 (32.80%) 41 (19.40)
Bleeding disorder 885 (2.96%) 367 (3.40%) 162 (2.10%) 296 (3.80%) 21 (1.40%) 22 (1.50%) 11 (4.50%) 6 (2.80%)
Ascites 12 (0.04%) 5 (0%) 2 (0%) 3 (0%) 0 (0%) 0 (0%) 2 (0.80%) 0 (0%)
Preoperative transfusion 79 (0.26%) 42 (0.40%) 7 (0.10%) 25 (0.30%) 1 (0.10%) 0 (0%) 3 (1.20%) 1 (0.50%)
Diabetes 3631 (12.14%) 1451 (13.30%) 745 (9.50%) 1118 (14.40%) 139 (9.10%) 125 (8.40%) 38 (15.60%) 15 (7.10%)
IDDM 1563 (5.23%) 676 (6.20%) 267 (3.40%) 497 (6.40%) 43 (2.80%) 53 (3.60%) 18 (7.40%) 9 (4.30%)
NIDDM 2068 (6.92%) 775 (7.10%) 478 (6.10%) 621 (8%) 96 (6.30%) 72 (4.90%) 20 (8.20%) 6 (2.80%)
COPD 943 (3.15%) 427 (3.90%) 156 (2%) 280 (3.60%) 30 (2%) 31 (2.10%) 14 (5.70%) 5 (2.40%)

BMI: body mass index; ASA: American Society of Anesthesiologists; Hypertension: hypertension requiring medication; Dialysis: acute or chronic renal failure requiring dialysis within 2 weeks of indexed procedure; COPD: chronic obstructive pulmonary disease; IDDM: insulin-dependent diabetes mellitus; NIDDM: non-insulin-dependent diabetes mellitus